Biogen Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $6.94B | $14.80B | $1.05B |
| FY2024 | $6.30B | $16.72B | $2.38B |
| FY2025 | $6.29B | $18.26B | $3.01B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $6.94B | $14.80B | $1.05B |
| FY2024 | $6.30B | $16.72B | $2.38B |
| FY2025 | $6.29B | $18.26B | $3.01B |